Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of BIKEN live attenuated varicella-zoster vaccine in adults ≥50 years with immune-affecting underlying diseases
jRCT1080223360Completed
- Sponsor
- Research Foundation for Microbial Diseases of Osaka University
- Start
- Oct 2016
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of Varicella vaccine live attenuated (Shenzhen Mellow Hope) in herpes zoster (HZ) and Varicella zoster infection, sponsored by Research Foundation for Microbial Diseases of Osaka University. Started Oct 2016; status: completed.
02
Drugs
Varicella vaccine live attenuated (Shenzhen Mellow Hope)
03
Conditions
herpes zoster (HZ)Varicella zoster infection
Beyond the preview
Go deeper on jRCT1080223360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223360.